Oppenheimer Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.96M Sell
8,193
-3,879
-32% -$1.03M 0.04% 420
2026
Q1
$1.32M Buy
12,072
+3,015
+33% +$429K 0.02% 660
2025
Q4
$1.51M Buy
9,057
+3,813
+73% +$638K 0.02% 577
2025
Q3
$1.03M Sell
5,244
-10,235
-66% -$1.68M 0.01% 749
2025
Q2
$1.4M Sell
15,479
-516
-3% -$40.8K 0.02% 674
2025
Q1
$954K Buy
15,995
+6,783
+74% +$627K 0.01% 727
2024
Q4
$1.22M Sell
9,212
-5,125
-36% -$481K 0.01% 669
2024
Q3
$751K Buy
+14,337
New +$673K 0.01% 792

Other funds holding ALAB

Oppenheimer Asset Management's ALAB Position: Q2 2026 in Review

Oppenheimer Asset Management reduced its Astera Labs (ALAB) stake by 32% in Q2 2026, selling an estimated $1.03M and leaving 8,193 shares worth $3.96M. The position accounts for 0.04% of the portfolio, ranked #420.

Oppenheimer Asset Management first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Oppenheimer Asset Management held 8,193 shares of Astera Labs worth $3.96M as of Q2 2026.
  • Oppenheimer Asset Management sold 3,879 Astera Labs shares in Q2 2026, an estimated $1.03M.
  • Astera Labs made up 0.04% of Oppenheimer Asset Management's portfolio in Q2 2026, its #420 holding.
  • Oppenheimer Asset Management first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.